Search

Your search keyword '"Perkins, DO"' showing total 360 results

Search Constraints

Start Over You searched for: Author "Perkins, DO" Remove constraint Author: "Perkins, DO"
360 results on '"Perkins, DO"'

Search Results

1. Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study

2. Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis.

3. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning

4. Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.

6. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

7. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

8. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium

9. Substance use in individuals at clinical high risk of psychosis

10. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high‐risk sample

11. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.

12. Frisky CALF outruns LASSO

13. The association between migrant status and transition in an ultra-high risk for psychosis population

14. Advanced Diffusion Imaging in Psychosis Risk: a cross-sectional and longitudinal study of white matter development

15. Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness

16. Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia

17. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases

18. Age at first birth in women is genetically associated with increased risk of schizophrenia

19. Biological insights from 108 schizophrenia-associated genetic loci

21. Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness Study

22. Fluoxetine treatment of depression in patients with HIV infection

23. Risperidone-induced dystonic reaction

24. A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).

26. A preliminary trial of adherence-coping-education (ACE) therapy for early psychosis.

27. Recognizing and responding to early psychosis: a qualitative analysis of individual narratives.

29. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.

30. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.

31. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.

32. Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation.

33. Practice guideline for the treatment of patients with schizophrenia, second edition.

34. Psychosocial predictors of high-risk sexual behavior among HIV-negative homosexual men.

35. The history of the NGAUS

38. Markers for schizophrenia.

39. Review: longer duration of untreated psychosis is associated with worse outcome in people with first episode psychosis.

40. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

41. Unique Functional Neuroimaging Signatures of Genetic Versus Clinical High Risk for Psychosis.

42. Robust Brain Correlates of Cognitive Performance in Psychosis and Its Prodrome.

43. Mismatch Negativity as an Index of Auditory Short-Term Plasticity: Associations with Cortisol, Inflammation, and Gray Matter Volume in Youth at Clinical High Risk for Psychosis.

44. Longitudinal Trajectories of Premorbid Social and Academic Adjustment in Youth at Clinical High Risk for Psychosis: Implications for Conversion.

45. Neighborhood ethnoracial diversity and positive psychotic symptoms among youth at high-risk and healthy comparisons.

46. Impact of adverse childhood experiences on risk for internalizing psychiatric disorders in youth at clinical high-risk for psychosis.

47. The Complex Latent Structure of Attenuated Psychotic Symptoms: Hierarchical and Bifactor Models of SIPS Symptoms Replicated in Two Large Samples at Clinical High Risk for Psychosis.

48. Attention Deficit Hyperactivity Disorder Among Youth at Clinical High Risk of Psychosis.

49. Protective Factors Predict Resilient Outcomes in Clinical High-Risk Youth with the Highest Individualized Psychosis Risk Scores.

50. Sleep disturbance, suicidal ideation and psychosis-risk symptoms in individuals at clinical high risk for psychosis.

Catalog

Books, media, physical & digital resources